A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/1998
12/23/1998	WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998	WO1998057642A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998	WO1998057641A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998	WO1998057640A1 Alpha 1a adrenergic receptor antagonists
12/23/1998	WO1998057639A1 ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998	WO1998057638A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998	WO1998057632A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998	EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998	EP0885299A1 Wsx receptor and ligands
12/23/1998	EP0885217A1 Endothelin receptor antagonists
12/23/1998	EP0885215A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/23/1998	EP0714300B1 Methods for modulating the human sexual response
12/23/1998	CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds
12/23/1998	CA2430623A1 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/23/1998	CA2294591A1 Alpha 1a adrenergic receptor antagonists
12/23/1998	CA2294590A1 Alpha 1a adrenergic receptor antagonists
12/23/1998	CA2294549A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998	CA2294349A1 Alpha 1aadrenergic receptor antagonists
12/23/1998	CA2294346A1 Alpha 1a adrenergic receptor antagonists
12/23/1998	CA2294344A1 Alpha 1a adrenergic receptor antagonists
12/23/1998	CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998	CA2293408A1 Alpha 1a adrenergic receptor antagonists
12/23/1998	CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/22/1998	US5852059 Use of droloxifene for the treatment of protastic disease, endometriosis and obesity
12/22/1998	US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998	US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/18/1998	CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998	WO1998056913A1 Smad6 and uses thereof
12/17/1998	WO1998056820A1 Hm74a receptor
12/17/1998	WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998	WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998	CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998	CA2292339A1 Smad6 and uses thereof
12/16/1998	EP0884387A2 Human 7-transmembrane receptor HLWAR77
12/16/1998	EP0884316A1 Quinazoline-4-one AMPA antagonists
12/16/1998	EP0884310A1 Quinazolin-4-one ampa antagonists
12/16/1998	EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis
12/16/1998	EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/16/1998	CN1202152A 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
12/16/1998	CN1041203C Preparation of pyrazolopyridine compound
12/15/1998	US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant
12/15/1998	US5849803 Method of treating erectile dysfunction with nitroglycerine
12/15/1998	US5849774 Treatment of sepsis-induced acute renal failure
12/15/1998	US5849770 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
12/15/1998	US5849535 Human growth hormone variants
12/11/1998	CA2233584A1 7tm receptor hlwar77
12/10/1998	WO1998055606A2 Lactoferrin receptor genes of moraxella
12/10/1998	WO1998055505A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/10/1998	WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998	WO1998055479A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055475A1 Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
12/10/1998	WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998	WO1998055470A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055123A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055119A1 Antagonists of gonadotropin releasing hormone
12/10/1998	WO1998055116A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2292881A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2292880A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998	CA2292605A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2291829A1 Antagonists of gonadotropin releasing hormone
12/10/1998	CA2291647A1 Antagonists of gonadotropin releasing hormone
12/09/1998	EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998	EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998	EP0882736A1 LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
12/09/1998	EP0882718A1 Benzimidazole derivatives
12/09/1998	EP0882040A1 Antagonists of gonadotropin releasing hormone
12/09/1998	EP0882039A1 Endothelin receptor antagonists
12/09/1998	EP0881905A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
12/09/1998	EP0881891A1 Male contraceptive implant
12/09/1998	EP0636028A4 Self-assembling polynucleotide delivery system.
12/09/1998	CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate
12/09/1998	CN1041095C Steroid compounds for treatment of prostatic hypertrophy, and its medicinal composition thereof
12/08/1998	US5847159 1- ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
12/08/1998	US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998	US5846990 Substituted biphenyl isoxazole sulfonamides
12/08/1998	US5846975 Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/08/1998	US5846967 Natriuretic and anti-hypertensive compounds
12/08/1998	US5846965 3-aza and 3-oxa piperidone tachykinin antagonists
12/08/1998	US5846766 Oxytocin receptor and DNA coding therefor
12/08/1998	US5846712 Tumor suppressor gene, HIC-1
12/08/1998	CA2150609C Pyrimidine derivatives and pharmaceutical composition
12/08/1998	CA2053209C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
12/03/1998	WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998	WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998	WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998	WO1998054187A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998	WO1998054182A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
12/03/1998	WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998	WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998	CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998	CA2291258A1 Inhibitors of naaladase enzyme activity
12/03/1998	CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998	CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998	EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998	EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998	EP0880967A2 Nephroprotective drug
12/02/1998	EP0880524A1 New triazolopurines, method of preparing them and their use as drugs
12/02/1998	EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998	EP0880517A1 Quinazoline compounds

1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 562